Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
AMGEN
Scientific Title
A Phase 3 Multicenter, Randomized, Open Label, Active-controlled, Study of AMG 510 Versus Docetaxel for the Treatment of Previously Treated Locally Advanced and Unresectable or Metastatic NSCLC Subjects With Mutated KRAS p.G12C